文献速递免疫规划

不同佐剂猪δ冠状病毒灭活疫苗在小鼠中的研制与免疫原性评价

Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice.
PubMed 文献 · Vaccine · 2022-06-09

本研究用Al(OH)3和ODN2395两种佐剂制备猪δ冠状病毒灭活疫苗,并在小鼠中评估免疫效果。两种疫苗均能诱导高水平IgG和中和抗体,免疫后血清IFN-γ、IL-4和CXCL13显著升高,以PDCoV/2395组最高。组织病理学观察显示接种有助于小鼠抵抗PDCoV感染,PDCoV/2395疫苗免疫效果优于PDCoV/Al(OH)3疫苗。

要点

  • PDCoV/Al(OH)3与PDCoV/2395灭活疫苗均在小鼠中诱导高水平IgG和中和抗体。
  • 免疫后血清IFN-γ、IL-4和CXCL13显著升高,PDCoV/2395组达最高水平。
  • PDCoV/2395疫苗免疫效果优于PDCoV/Al(OH)3疫苗。

核心结论

  • 两种灭活疫苗均有良好免疫效果,PDCoV/2395疫苗因能诱导体液和细胞免疫而效果更好。
  • 本研究研制的PDCoV/2395灭活疫苗可能是预防PDCoV感染的有效工具。

研究设计与样本

  • 本研究用Al(OH)3和ODN2395两种不同作用机制的佐剂制备PDCoV灭活疫苗,并在小鼠中评估免疫效果。

主要发现

  • PDCoV/Al(OH)3疫苗和PDCoV/2395疫苗均能诱导小鼠产生高水平IgG和中和抗体。
  • 免疫后血清IFN-γ、IL-4和CXCL13显著升高,并在PDCoV/2395疫苗组达到最高水平。
  • 组织病理学观察显示接种有助于小鼠抵抗PDCoV感染。
  • PDCoV/2395疫苗免疫效果优于PDCoV/Al(OH)3疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine deltacoronavirus (PDCoV) is a novel coronavirus that causes diarrhea in pigs of various ages, especially in suckling piglets, and there are no effective measures to prevent and control PDCoV currently. In this study, two adjuvants Al(OH)3 and ODN2395 working through different mechanisms were used to prepare inactivated PDCoV vaccines, and the immune effects of PDCoV inactivated vaccines were assessed in mice. From the results, we found that both PDCoV/Al(OH)3 vaccine and PDCoV/2395 vaccine could induce IgG and neutralizing antibodies with high levels in mice. At the same time, cytokines of IFN-γ, IL-4 and chemokine ligand of CXCL13 in serum were significantly increased after immunization, and reached the highest levels in PDCoV/2395 vaccine group, which suggested that PDCoV/2395 could promote the production of both Th1 and Th2 polarized cytokines. In addition, histopathological observations showed that vaccination helped mice resist PDCoV infection. These results indicated that both the two inactivated vaccines have good immune effects. Moreover, the PDCoV/2395 vaccine worked better than the PDCoV/Al(OH)3 vaccine for PDCoV/2395 having the good ability to induce both humoral and cellular immunogenicity. The PDCoV/2395 inactivated vaccine developed in this study might be an effective tool for the prevention of PDCoV infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhao FJ, Liu LT, Wang Z, et al. Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice. Vaccine. 2022. PMID: 35691873. doi:10.1016/j.vaccine.2022.05.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。